Guardant Health
GH
#2467
Rank
NZ$10.37 B
Marketcap
$83.94
Share price
-0.50%
Change (1 day)
139.03%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company